Enlivex Therapeutics Ltd. (ENLV) 의 후행 P/E는 0.0. 후행 이익수익률은 2,942.33%. 그레이엄 넘버는 $161.39.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 66/100 3/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | -1.0 | 0.15 | 1.90 | 0.00 | - |
| 2017 | -1.2 | 0.02 | 2.33 | 0.00 | - |
| 2018 | -0.6 | 0.02 | 0.29 | 0.00 | - |
| 2019 | -7.7 | 0.09 | 6.43 | 0.00 | - |
| 2020 | -9.4 | 0.92 | 3.13 | 48.76 | - |
| 2021 | -7.7 | 0.16 | 1.31 | 0.00 | - |
| 2022 | -2.3 | -0.01 | 1.28 | 0.00 | - |
| 2023 | -1.7 | 0.05 | 1.67 | 0.00 | - |
| 2024 | -1.6 | 0.03 | 1.02 | 0.00 | - |
| 2025 | 0.0 | 0.00 | 0.02 | 0.00 | - |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2016 | $-40.29 | $0.00 | $-16.02M | - |
| 2017 | $-13.88 | $0.00 | $-5.95M | - |
| 2018 | $-1.21 | $0.00 | $-4.9M | - |
| 2019 | $-1.17 | $0.00 | $-9.38M | - |
| 2020 | $-1.05 | $2.28M | $-11.82M | -519.3% |
| 2021 | $-0.54 | $0.00 | $-14.47M | - |
| 2022 | $-2.31 | $0.00 | $-31.06M | - |
| 2023 | $-1.56 | $0.00 | $-29.07M | - |
| 2024 | $-0.73 | $0.00 | $-15.01M | - |
| 2025 | $25.48 | $0.00 | $1.24B | - |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $-0.32 | $-0.32 – $-0.32 | $0.00 | $0.00 – $0.00 | 1 |
| 2027 | $-0.78 | $-0.78 – $-0.78 | $0.00 | $0.00 – $0.00 | 1 |
| 2028 | $-0.94 | $-0.94 – $-0.94 | $0.00 | $0.00 – $0.00 | 1 |
